GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Polarean Imaging PLC (LSE:POLX) » Definitions » Sloan Ratio %

Polarean Imaging (LSE:POLX) Sloan Ratio % : -9.68% (As of Jun. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Polarean Imaging Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Polarean Imaging's Sloan Ratio for the quarter that ended in Jun. 2023 was -9.68%.

As of Jun. 2023, Polarean Imaging has a Sloan Ratio of -9.68%, indicating the company is in the safe zone and there is no funny business with accruals.


Polarean Imaging Sloan Ratio % Historical Data

The historical data trend for Polarean Imaging's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polarean Imaging Sloan Ratio % Chart

Polarean Imaging Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Sloan Ratio %
Get a 7-Day Free Trial -7.86 -16.14 -6.20 -3.55 -7.03

Polarean Imaging Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.31 -3.30 -1.65 -6.98 -9.68

Competitive Comparison of Polarean Imaging's Sloan Ratio %

For the Medical Devices subindustry, Polarean Imaging's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Polarean Imaging's Sloan Ratio % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Polarean Imaging's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Polarean Imaging's Sloan Ratio % falls into.



Polarean Imaging Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Polarean Imaging's Sloan Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Sloan Ratio=(Net Income (A: Dec. 2022 )-Cash Flow from Operations (A: Dec. 2022 )
-Cash Flow from Investing (A: Dec. 2022 ))/Total Assets (A: Dec. 2022 )
=(-11.417--10.064
--0.053)/18.503
=-7.03%

Polarean Imaging's Sloan Ratio for the quarter that ended in Jun. 2023 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Jun. 2023 )
=(-11.558--10.432
-0.078)/12.434
=-9.68%

For company reported semi-annually, GuruFocus uses latest two semi-annual data as the TTM data. Polarean Imaging's Net Income for the trailing twelve months (TTM) ended in Jun. 2023 was -5.736 (Dec. 2022 ) + -5.822 (Jun. 2023 ) = £-11.56 Mil.
Polarean Imaging's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2023 was -5.11 (Dec. 2022 ) + -5.322 (Jun. 2023 ) = £-10.43 Mil.
Polarean Imaging's Cash Flow from Investing for the trailing twelve months (TTM) ended in Jun. 2023 was -0.046 (Dec. 2022 ) + 0.124 (Jun. 2023 ) = £0.08 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Polarean Imaging  (LSE:POLX) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Jun. 2023, Polarean Imaging has a Sloan Ratio of -9.68%, indicating the company is in the safe zone and there is no funny business with accruals.


Polarean Imaging Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Polarean Imaging's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Polarean Imaging (LSE:POLX) Business Description

Traded in Other Exchanges
Address
27-28 Eastcastle Street, London, GBR, W1W 8DH
Polarean Imaging PLC designs and manufactures medical drug-device combination companies operating in the high-resolution medical imaging market. Its only operating segment being the development and commercialization of gas polariser devices and ancillary instruments. Geographically, it derives most of the revenue from the United States of America and also has a presence in Canada and the United Kingdom. The company generates revenue from products and services such as Polarisers, Parts and Upgrades, Service and other revenue. Its product portfolio includes 9820 129Xe Hyperpolarizer, 9800 129Xe Hyperpolarizer, Polarean 3777 129Xe Hyperpolarizer Upgrade Module, Polarean 2881 Polarization Measurement Station, and others.

Polarean Imaging (LSE:POLX) Headlines

No Headlines